Retatrutide is expected to be commercially available in 2026 or 2027
In laboratory settings, IGF-1 LR3 has been studied across a remarkably broad range of biological systems
In early March, Swiss pharma giant Roche put out some good news about the obesity drug candidate Petrelintide its developing with Danish biotech Zealand Pharma
Atypical attentional networks and the emergence of autism
News provided by MENU - ORDER AI Mar 30, 2026, 18:10 ET Positioned at the center of a major healthcare shift, Menu-Order-AI is emerging as the real-world decision layer for millions of GLP-1 users BOSTON, March 30, 2026 /PRNewswire/ -- MENU - ORDER AI , the AI-powered dining companion helping users choose high-protein, GLP-1 friendly meals in seconds, announced today that it has become the #1 app searched for GLP-1 meal guidance on the Apple App Store in the United States
With diabetes and obesity cases surging in India, pharmaceutical giant Eli Lilly and Company (India) has launched Mounjaro (tirzepatide), a once-weekly injectable drug for chronic weight management and type 2 diabetes
